Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand

Author: Tawatchai Apidechkul

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Hepatitis B virus (HBV) infection is a major viral infection, particularly in people living in the Western Pacific region, including the hill tribe people living in northern Thailand. This study aimed to estimate the prevalence of HBV infection and to detect the factors associated with HBV infection among hill tribe youths in Thailand.

Methods

A cross-sectional study was conducted to estimate the prevalence and determine the factors associated with HBV infection among hill tribe youths living in northern Thailand. A validated questionnaire and 5 mL blood sample were used for data collection. The Wondfo Diagnostic Kit®, the Wondfo One Step HBsAg Serum/Plasma Test®, and the Wondfo One Step HBsAg Serum/Plasma Test® were used for anti-HBsAg, HBsAg, and total anti-HBc detections, respectively. Logistic regression was used to detect associations between variables with an α = 0.05 significance level.

Results

A total of 836 participants were included in the study; 62.7% were female, 58.9% were aged 15–17 years, 58.7% were Buddhist, 78.4% graduated high school, and 89.1% had no income. The majority were Akha (30.0%), Yao (16.3%), and Hmong (15.8%); 13.2% smoked, 21.5% used alcohol, 13.3% had tattoos, 3.9% experienced drug injection from illegal practitioners, and 35.7% had no history of HBV immunization. The prevalence of HBsAg was 3.0%; anti-HBs, 10.2%; and total anti-HBc, 8.1%. In the multivariate analysis, four variables were found to be significantly associated with HBV infection among the hill tribe youths: age, tribe, work experience, and number of partners. Those aged 18–20 years and 21–24 years had 2.13 times (95%CI = 1.35–3.29) and 2.39 times (95%CI = 1.05–3.90) greater odds of HBV infection, respectively, than those aged 15–17 years. Akha, Lahu, and Hmong youths had 3.12 times (95%CI = 1.07–9.12), 3.71 times (95%CI = 1.21–11.41), and 3.84 times (95%CI = 1.26–11.69) greater odds of HBV infection, respectively, than Lisu youths. Those who had experience working outside of the village had a 1.77 times (95%CI = 1.18–2.98) greater chance of HBV infection than those who did not have experience working outside of the village, and those who had ≥2 partners had a 2.66 times (95%CI = 1.96–3.87) greater chance of HBV infection than those who had no partner.

Conclusions

Effective HBV prevention programs should be promoted in Akha, Lahu, and Hmong youth populations, particularly to those who have sexual partners, work outside of the village and are aged 18–24 years.
Literature
2.
go back to reference World Health Organization (WHO). Guidelines on hepatitis B and C testing. http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/. World Health Organization (WHO). Guidelines on hepatitis B and C testing. http://​www.​who.​int/​hepatitis/​publications/​hepatitis-b-guidelines/​en/​.​
6.
go back to reference Lisa PW, Vrushak D, Nikolaos P. Hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2015;7(26):2648–63.CrossRef Lisa PW, Vrushak D, Nikolaos P. Hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2015;7(26):2648–63.CrossRef
8.
go back to reference Xu C, Chen T. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission. Lancet Gastroenterol Hepatol. 2018;3(9):598–9.CrossRef Xu C, Chen T. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission. Lancet Gastroenterol Hepatol. 2018;3(9):598–9.CrossRef
11.
go back to reference Lukas H. Southeast Asian hill tribes and the opium trade – The historical and social-economic background of the marginalization of minorities using the example of Thailand. Austria: University of Vienna. p. 2017. Lukas H. Southeast Asian hill tribes and the opium trade – The historical and social-economic background of the marginalization of minorities using the example of Thailand. Austria: University of Vienna. p. 2017.
13.
go back to reference Apidechkul T, Jiamton S, Jareinpituk S, Kaewkungwal J. Sexual behaviors and HIV infection among pregnant hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2007;38(6):1061–9. Apidechkul T, Jiamton S, Jareinpituk S, Kaewkungwal J. Sexual behaviors and HIV infection among pregnant hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2007;38(6):1061–9.
14.
go back to reference Apidechkul T, Laingoen O, Suwannaporn S. Inequity in accessing health care service in Thailand in 2015: a case study of the hill tribe people in Mae Fah Luang district, Chiang Rai, Thailand. J Health Res. 2016;30(1):67–71. Apidechkul T, Laingoen O, Suwannaporn S. Inequity in accessing health care service in Thailand in 2015: a case study of the hill tribe people in Mae Fah Luang district, Chiang Rai, Thailand. J Health Res. 2016;30(1):67–71.
16.
go back to reference The hill tribe welfare and development center, Chiang Rai province. Hill tribe population. The hill tribe welfare and development center. Chiang Rai: Ministry of Interior; 2016. p. 13–21. The hill tribe welfare and development center, Chiang Rai province. Hill tribe population. The hill tribe welfare and development center. Chiang Rai: Ministry of Interior; 2016. p. 13–21.
17.
go back to reference Peter B, Leslie EW, Mark RS, Charles EM. Ethic and sample size. Am J Epidemiol. 2005;161(2):105–10.CrossRef Peter B, Leslie EW, Mark RS, Charles EM. Ethic and sample size. Am J Epidemiol. 2005;161(2):105–10.CrossRef
18.
go back to reference Leroi C, Adam P, Khamduang W, Kawilapat S, Neo-Giang-Huong, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. In J Infect Dis 2016; 51: 136–43. Leroi C, Adam P, Khamduang W, Kawilapat S, Neo-Giang-Huong, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. In J Infect Dis 2016; 51: 136–43.
19.
go back to reference Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63.CrossRef Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63.CrossRef
21.
go back to reference Lana C, Sigrun R, Rania AT. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 2992-2015. Vaccine. 2018;36(1):6–14.CrossRef Lana C, Sigrun R, Rania AT. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 2992-2015. Vaccine. 2018;36(1):6–14.CrossRef
25.
go back to reference Apidechkul T, Wongnuch P, Sithisarn S, Ruanjai T. Health status of Akha hill tribe in Chiang Rai province, Thailand. J Pub Health Dev. 2016;14(1):77–97. Apidechkul T, Wongnuch P, Sithisarn S, Ruanjai T. Health status of Akha hill tribe in Chiang Rai province, Thailand. J Pub Health Dev. 2016;14(1):77–97.
26.
go back to reference Scott DP, Inna GO, Gregory AP. The weight of obesity on the human immune response to vaccine. Vaccine. 2015;33(36):4422–9.CrossRef Scott DP, Inna GO, Gregory AP. The weight of obesity on the human immune response to vaccine. Vaccine. 2015;33(36):4422–9.CrossRef
27.
go back to reference Anja S, Beate K. Vaccine responses in newborns. Semin Immunopathol. 2017;39(6):627–42.CrossRef Anja S, Beate K. Vaccine responses in newborns. Semin Immunopathol. 2017;39(6):627–42.CrossRef
28.
go back to reference Teresa A, Jane B, John RB, Bonnie BB, Wilbur HC, Julian H, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 march 2017. Vaccine. 2018;36(7):921–31.CrossRef Teresa A, Jane B, John RB, Bonnie BB, Wilbur HC, Julian H, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 march 2017. Vaccine. 2018;36(7):921–31.CrossRef
29.
go back to reference Pham TT, Le HM, Nguyen DT, Maertens K, Leuridan E, Theeten H, et al. Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Vietnam. Vaccine. 2018;36(38):5760–5.CrossRef Pham TT, Le HM, Nguyen DT, Maertens K, Leuridan E, Theeten H, et al. Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Vietnam. Vaccine. 2018;36(38):5760–5.CrossRef
30.
go back to reference Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doggany L. Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J Gastroenterol. 2018;24(30):3347–60.CrossRef Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doggany L. Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J Gastroenterol. 2018;24(30):3347–60.CrossRef
32.
go back to reference Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, et al. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400–7.CrossRef Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, et al. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400–7.CrossRef
33.
go back to reference Banks T, Kang J, Watts I, Tyrosvoutis ME, Min AM, Tun NW, et al. High hepatitis B seroprevalence and risk factors for infection in pregnant women on the Thailand-Myanmar border. J Infect Dev Ctries. 2016;10(4):384–8.CrossRef Banks T, Kang J, Watts I, Tyrosvoutis ME, Min AM, Tun NW, et al. High hepatitis B seroprevalence and risk factors for infection in pregnant women on the Thailand-Myanmar border. J Infect Dev Ctries. 2016;10(4):384–8.CrossRef
34.
go back to reference Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, et al. Seroprevalence of hepatitis B among HIV-infected children and adolescents receiving antiretroviral therapy in the TREAT Asia pediatric HIV observational database. Pediatr Infect Dis J. 2018;37(8):788–93.CrossRef Aurpibul L, Kariminia A, Vibol U, Fong MS, Le ON, Hansudewechakul R, et al. Seroprevalence of hepatitis B among HIV-infected children and adolescents receiving antiretroviral therapy in the TREAT Asia pediatric HIV observational database. Pediatr Infect Dis J. 2018;37(8):788–93.CrossRef
35.
go back to reference Pichainarong N, Chaveepojnkamjorn W, Luksamijarulkul P, Sujirarat D, Apidechkul T. Hepatitis B carrier among married hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2003;34(1):114–9.PubMed Pichainarong N, Chaveepojnkamjorn W, Luksamijarulkul P, Sujirarat D, Apidechkul T. Hepatitis B carrier among married hill tribe women in northern Thailand. Southeast Asian J Trop Med Public Health. 2003;34(1):114–9.PubMed
37.
go back to reference Teerapat U, Tassanee S, Pattama K, Pitchayachuda C, Kamonwan S, Gaidganok S, et al. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients. Medicine (Baltimore). 2017;96(13):e6554.CrossRef Teerapat U, Tassanee S, Pattama K, Pitchayachuda C, Kamonwan S, Gaidganok S, et al. Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients. Medicine (Baltimore). 2017;96(13):e6554.CrossRef
38.
go back to reference Catherine MN, John SL. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404.CrossRef Catherine MN, John SL. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395–404.CrossRef
39.
go back to reference Teleban R, Moafi M, Ataei B, Yaran M, Nokhodian Z, Kassaian N, et al. Seroprevalence of hepatitis B infection and associated risk factors among drug users in drop-in centers of Isfahan, Iran. Int J Prev Med. 2018;9(46) DOI: 10.4103. Teleban R, Moafi M, Ataei B, Yaran M, Nokhodian Z, Kassaian N, et al. Seroprevalence of hepatitis B infection and associated risk factors among drug users in drop-in centers of Isfahan, Iran. Int J Prev Med. 2018;9(46) DOI: 10.4103.
40.
go back to reference Demsiss W, Seil A, Fiseha T. Hepatitis B and C: seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia. PLoS One. 2018;13(5):e0196539.CrossRef Demsiss W, Seil A, Fiseha T. Hepatitis B and C: seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia. PLoS One. 2018;13(5):e0196539.CrossRef
41.
go back to reference Moradi G, Gouya MM, Azimizan ZF, Mohamadi BA, Darvishi S, Aghasadeghi MR, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran; a national bio-behavioral surveillance survey in 2015. Tropical Med Int Health. 2018;23(6):641–9.CrossRef Moradi G, Gouya MM, Azimizan ZF, Mohamadi BA, Darvishi S, Aghasadeghi MR, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran; a national bio-behavioral surveillance survey in 2015. Tropical Med Int Health. 2018;23(6):641–9.CrossRef
42.
43.
go back to reference Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, infectivity, and associated risk factors on hepatitis B virus among pregnant women in Yirgalem hospital, Ethiopia: implication of screening to control mother-to-child transmission. J Pregnancy. 2018:8435910. https://doi.org/10.1155/2018/8435910. Amsalu A, Ferede G, Eshetie S, Tadewos A, Assegu D. Prevalence, infectivity, and associated risk factors on hepatitis B virus among pregnant women in Yirgalem hospital, Ethiopia: implication of screening to control mother-to-child transmission. J Pregnancy. 2018:8435910. https://​doi.​org/​10.​1155/​2018/​8435910.​
44.
go back to reference Kapinga D, Aboud S. Seroprevalence and factors associated with hepatitis B virus infection in pregnant women attending antenatal clinic in Karagwe district council, Tanzania. Int J Infect Dis. 2018;73(Supp):369.CrossRef Kapinga D, Aboud S. Seroprevalence and factors associated with hepatitis B virus infection in pregnant women attending antenatal clinic in Karagwe district council, Tanzania. Int J Infect Dis. 2018;73(Supp):369.CrossRef
45.
go back to reference Xaydalasouk K, Strobel M, Buisson Y, Black AP, Muller CP. Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories. PLoS One. 2018;13(7):e0199919.CrossRef Xaydalasouk K, Strobel M, Buisson Y, Black AP, Muller CP. Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories. PLoS One. 2018;13(7):e0199919.CrossRef
46.
go back to reference Linkins RW, Chonwattana W, Holtz TH, Wasinrapee P, Chaikummao S, Varangrat A, et al. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008. J Med Virol. 2013;85(9):1499–505.CrossRef Linkins RW, Chonwattana W, Holtz TH, Wasinrapee P, Chaikummao S, Varangrat A, et al. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008. J Med Virol. 2013;85(9):1499–505.CrossRef
47.
go back to reference Apidechkul T, Pongwiriyakul S. Factors associated with HIV and HBV co-infection in northern Thailand. Asian Pac J Trop Dis. 2016;6(3):174–8.CrossRef Apidechkul T, Pongwiriyakul S. Factors associated with HIV and HBV co-infection in northern Thailand. Asian Pac J Trop Dis. 2016;6(3):174–8.CrossRef
48.
go back to reference Apidechkul T. Epidemiology of the hill tribe HIV/AIDS populations, Thailand. J Med Assoc Thail. 2016;99(6):703–8. Apidechkul T. Epidemiology of the hill tribe HIV/AIDS populations, Thailand. J Med Assoc Thail. 2016;99(6):703–8.
49.
go back to reference Jobayer M, Chowdhury SS, Shamsuzzaman SM, Islam MS. Prevalence of hepatitis B virus, hepatitis C virus, and HIV in overseas job seekers of Bagladesh with the possible routes of transmission. Mymensigngh Med J. 2016;25(3):530–5. Jobayer M, Chowdhury SS, Shamsuzzaman SM, Islam MS. Prevalence of hepatitis B virus, hepatitis C virus, and HIV in overseas job seekers of Bagladesh with the possible routes of transmission. Mymensigngh Med J. 2016;25(3):530–5.
50.
go back to reference Bakarey AS, Akinboade IO, Aken’Ova YA. Transmission transmissible hepatitis B virus markers of infection among sickle cell disease patients receiving care at a tertiary health facility in Ibadan, southwest Nigeria. J Immunoassay Immunochem. 2018;39(4):416–27.CrossRef Bakarey AS, Akinboade IO, Aken’Ova YA. Transmission transmissible hepatitis B virus markers of infection among sickle cell disease patients receiving care at a tertiary health facility in Ibadan, southwest Nigeria. J Immunoassay Immunochem. 2018;39(4):416–27.CrossRef
51.
go back to reference Coughlin SS. Recall bias in epidemiological studies. J Cli Epidemiol. 1990;43(1):87–91.CrossRef Coughlin SS. Recall bias in epidemiological studies. J Cli Epidemiol. 1990;43(1):87–91.CrossRef
52.
go back to reference Belbasis L, Bellou V. Introduction to epidemiological studies. Methods Mol Biol. 1793;2018:1–6. Belbasis L, Bellou V. Introduction to epidemiological studies. Methods Mol Biol. 1793;2018:1–6.
Metadata
Title
Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand
Author
Tawatchai Apidechkul
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Hepatitis B
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3747-3

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue